Predictive Factors for Renal Response in Lupus Nephritis: A Single-center Prospective Cohort Study

To identify the predictive factors for renal response in patients with lupus nephritis (LN). Patients and data were extracted from a prospective systemic lupus erythematosus cohort in Korea, in which clinical data were collected at 0, 3, 6, and 12 months after induction therapy. Treatment response o...

Full description

Saved in:
Bibliographic Details
Published inJournal of rheumatic diseases Vol. 29; no. 4; pp. 223 - 231
Main Authors Park, Dae Jin, Joo, Young Bin, Bang, So-Young, Lee, Jiyoung, Lee, Hye-Soon, Bae, Sang-Cheol
Format Journal Article
LanguageEnglish
Published Korea (South) Korean College of Rheumatology 01.10.2022
대한류마티스학회
Subjects
Online AccessGet full text
ISSN2093-940X
2233-4718
DOI10.4078/jrd.22.0006

Cover

More Information
Summary:To identify the predictive factors for renal response in patients with lupus nephritis (LN). Patients and data were extracted from a prospective systemic lupus erythematosus cohort in Korea, in which clinical data were collected at 0, 3, 6, and 12 months after induction therapy. Treatment response of LN were evaluated as a complete response (CR), partial response (PR), or non-response (NR) at 3, 6, and 12 months, respectively. Predictive factors for CR at 6 months were evaluated using multivariable Poisson regression analysis. A total of 75 patients with LN who underwent biopsy was enrolled. The mean age at diagnosis of LN was 28.9±9.7 years, and 68 (90.7%) were female. The frequencies of classes III, IV, III+V, IV+V, and V were 20.0%, 44.0%, 16.0%, 12.0%, and 8.0%, respectively. Compared to relapsed LN, new-onset LN showed a lower percentage of glomerulosclerosis (45.5% vs. 76.2%, p=0.013). The overall proportions of CR, PR, and NR at 6 and 12 months were 52.0%, 26.7%, 21.3% and 50.7%, 24.0%, 25.3%, respectively. In multivariate analysis, age at enrollment (odds ratio [OR]=1.02, p=0.022), relapsed LN (OR=0.71, p=0.037), anti-Ro antibody (OR=0.67, p=0.014), and class III LN (OR=1.48, p=0.001) were associated with CR at 6 months. In our prospective cohort, class III LN was a good predictive factor for CR at 6 months in patients with LN, whereas younger age, relapsed LN, and anti-Ro antibody were poor predictive factors.
ISSN:2093-940X
2233-4718
DOI:10.4078/jrd.22.0006